BioDuro, a global integrated contract research, development and manufacturing organization (CRDMO), today announced the appointment of Greg Makara, Ph.D., as Senior Vice President Lead Discovery ...
Agentic AI, ultralarge virtual screening, molecular glues and human-relevant models were among the key developments in early ...
Two structurally modified compounds derived from an anti-inflammatory metabolite demonstrated enhanced anti-inflammatory ...
Lead discovery is the phase of drug development in which researchers find and validate chemical starting points (“hits”) that interact with an established biological target. The strongest hits are ...
Drug discovery is in the midst of one of the most consequential transformations in its history, and a sweeping special issue of the journal Molecular Diversity, published in September 2026, captures ...
AI, automation and computational tools are accelerating drug discovery, while precision medicine, multiomics and industry partnerships expand targeted therapy opportunities.Dublin, Sept. (GLOBE ...
AI-driven screening, cloud platforms, predictive toxicology and precision medicine are accelerating drug discovery, while cost-efficient tools and local infrastructure create opportunities.Dublin, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results